A long-term study of young survivors of aneurysmal subarachnoid hemorrhage has found that the risk of developing a new brain aneurysm may continue rising for decades. The population-based cohort study, published in JAMA Neurology, followed 544 people who had survived an aneurysmal subarachnoid hemorrhage before the age of 40. During follow-up, 19.5% developed a radiologically detected de novo intracranial aneurysm, meaning an aneurysm that was not present or identified at the time of the original hemorrhage. By 40 years, the estimated cumulative incidence had reached 30.2%, suggesting that the risk does not simply level off after the initial recovery period.
Aneurysmal subarachnoid hemorrhage occurs when a weakened area in a brain artery ruptures and releases blood into the space surrounding the brain. It is a medical emergency that can cause sudden, severe headache, loss of consciousness, neurological disability, or death. Although treatment can prevent further bleeding from the original aneurysm, the underlying vulnerability of the cerebral blood vessels may persist. A de novo aneurysm can form in a different part of the arterial system years or even decades later, creating a new potential source of hemorrhage. The new findings indicate that surviving the first event does not eliminate the possibility of future aneurysm formation, particularly among people who experience subarachnoid hemorrhage at a young age.
The study’s most striking result was the extended time scale over which new aneurysms appeared. Rather than showing a sharp increase followed by a stable plateau, the cumulative risk continued to grow across the 40-year follow-up estimates. This pattern is important because many medical surveillance strategies are designed around a limited period of elevated risk. If the risk remains measurable throughout adulthood, short-term imaging alone may fail to identify aneurysms that develop later in life. The findings therefore support a model of lifelong, risk-stratified surveillance, in which the timing and frequency of brain imaging are adjusted according to each patient’s clinical and familial risk profile.
The aneurysms were detected radiologically through systematic follow-up rather than only after symptoms developed. Depending on the clinical setting, imaging for intracranial aneurysms may include magnetic resonance angiography, computed tomography angiography, or catheter-based digital subtraction angiography. These techniques visualize the brain’s arteries and can identify small outpouchings in the vessel wall before they rupture. Detecting an aneurysm before rupture can create an opportunity for continued observation, preventive treatment, or closer monitoring, depending on its size, location, shape, growth pattern, and the patient’s overall risk. The study reported no de novo ruptures under systematic surveillance, although this result should not be interpreted as proof that every newly detected aneurysm is harmless.
Three factors were independently associated with the formation of de novo aneurysms: female sex, smoking, and a family history of intracranial aneurysm. The independent association means that each factor remained linked to aneurysm development even after the analysis accounted for other variables included in the study. The biological mechanisms are complex. Differences in vascular biology and hormonal influences may contribute to the higher risk observed among women, while inherited differences in the structure or maintenance of arterial walls may partly explain familial clustering. A family history may also reflect shared environmental exposures, but genetic susceptibility is thought to be an important component in some families.
Smoking emerged as one of the most actionable risk factors. Tobacco smoke exposes blood vessels to chemicals that can promote inflammation, oxidative stress, endothelial dysfunction, and structural damage to the arterial wall. These processes may make existing aneurysms more likely to enlarge and may also contribute to the formation of new ones. The study found that smoking cessation was associated with a lower risk of de novo aneurysm formation, adding to extensive evidence that quitting tobacco benefits cerebrovascular health. For young survivors of subarachnoid hemorrhage, smoking cessation is not merely a general lifestyle recommendation; it may be a central part of preventing a second vascular event over a lifetime.
The results also carry implications for how clinicians counsel patients after treatment of a ruptured aneurysm. A person who recovers from the original hemorrhage may understandably view the event as over once the aneurysm has been clipped, coiled, or otherwise secured. However, the new findings suggest that the condition should be considered a continuing vascular disorder rather than an isolated episode. Follow-up decisions may need to incorporate age at the first hemorrhage, sex, tobacco exposure, family history, the presence of additional aneurysms, and findings from earlier imaging. A single universal screening schedule may not be appropriate for every survivor, but the evidence favors maintaining surveillance over the long term instead of ending it after a few reassuring scans.
The absence of observed de novo ruptures during systematic surveillance is particularly relevant to the debate over screening and preventive intervention. Many small aneurysms never rupture, and treating every radiologically detected lesion could expose patients to unnecessary procedural risks. At the same time, an aneurysm that is discovered before rupture can be assessed in a controlled setting, when treatment decisions are less urgent than they would be during an active hemorrhage. The study’s findings therefore point toward a balanced strategy: continued imaging to detect changes, individualized assessment of rupture risk, and careful selection of patients who might benefit from an intervention. The data do not establish that surveillance prevents all future hemorrhages, nor do they define the ideal imaging interval for every patient.
Because this was a population-based cohort study, its results reflect real-world patterns across a defined group rather than the effects of a randomized treatment. Observational research can identify associations but cannot prove that smoking directly caused a particular aneurysm to form or that cessation alone prevented it. The study also focused on survivors younger than 40 at the time of their original aneurysmal subarachnoid hemorrhage, so the findings may not apply in exactly the same way to older patients or to people who have never experienced a hemorrhage. Nevertheless, the large time horizon and systematic follow-up provide an unusually detailed view of what may happen across the decades following early-life brain hemorrhage.
For patients and families, the message is both cautionary and practical. A history of aneurysmal subarachnoid hemorrhage at a young age may carry a persistent risk of developing another aneurysm, but that risk can be evaluated rather than ignored. Regular communication with a neurologist, neurosurgeon, or cerebrovascular specialist can help determine an appropriate surveillance plan. People with a family history of intracranial aneurysm may also need individualized counseling about imaging and risk reduction. Most importantly, stopping smoking appears to be a meaningful step toward lowering future risk. The study’s broader warning is that the consequences of a ruptured brain aneurysm may extend far beyond the original emergency, while its clearest opportunity for prevention may begin with lifelong monitoring and tobacco cessation.
Subject of Research: Long-term formation of de novo intracranial aneurysms in young survivors of aneurysmal subarachnoid hemorrhage.
Web References: https://doi.org/10.1001/jamaneurol.2026.2830
References: Alpkvist P, et al. Study published in JAMA Neurology. DOI: 10.1001/jamaneurol.2026.2830.
Keywords: aneurysmal subarachnoid hemorrhage, intracranial aneurysm, de novo aneurysm, brain aneurysm, neurology, radiological surveillance, smoking cessation, family history, female sex, cerebrovascular disease, cohort study, long-term risk
Tags: aneurysm formation decades after hemorrhageaneurysm prevention strategiescerebral blood vessel vulnerabilitycohort study on aneurysm survivorsde novo intracranial aneurysmsJAMA Neurology aneurysm researchlifelong aneurysm risklong-term neurological outcomeslong-term risk of recurrent brain aneurysmsrisk factors for aneurysm developmentsubarachnoid hemorrhage recurrenceyoung aneurysm survivors
